Fintel reports that on November 27, 2024, BTIG upgraded their outlook for Embecta (NasdaqGS:EMBC) from Neutral to Buy. Analyst Price Forecast Suggests 20.45% Downside As of November 21, 2024, the ...

Specialty Finance Analyst Caintic holds a meeting with CEO Howard and CFO McCamey in Boston on December 4 hosted by BTIG.Don't Miss our Black ...

BTIG analyst Gray Powell raised the firm’s price target on Zscaler (ZS) to $238 from $205 and keeps a Buy rating on the shares. The firm’s ...

On Tuesday, Vuzix Corp (VUZI) stock saw a decline, ending the day at $1.97 which represents a decrease of $-0.28 or -12.44% from the prior close of $2.25. The stock opened at $2.38 and touched a low ...

Notable insider trades include Wang Junyuan Jerry, CEO, ANHEART THERAPEUTICS LTD. at Nuvation Bio Inc (NUVB), who sold 56361 shares on Nov 11 ’24, at $2.89 each, totaling $0.16 million.

Tech was leading the way lower for stocks Wednesday. BTIG Chief Market Technician Jonathan Krinsky noted that while tech ...

It isn't all bad news, said John Krinsky, chief market technician at BTIG, in a Wednesday client note. Tech's XLK 1.5% fall ...

Embecta (EMBC) stock gains as BTIG upgrades the stock citing an end to its patch pump program announced with its Q4 FY24 results. Read more here.

Glaukos (NYSE:GKOS – Free Report) had its price target lifted by BTIG Research from $140.00 to $149.00 in a report published on Tuesday,Benzinga reports. BTIG Research currently has a buy rating on ...

Alector (NASDAQ:ALEC – Free Report) had its target price lowered by BTIG Research from $16.00 to $5.00 in a research note ...

Investors should start looking at restaurant names that have timely setups, said Jonathan Krinsky, chief market technician at ...

"An effort to repeal the IRA's tax credits would be met with opposition from numerous fronts, including constituencies supporting solar, wind, nuclear, hydrogen, hydro, alternative fuels and energy ...